Pavion Blue Capital’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Buy
+550
New +$157K 0.09% 103
2024
Q4
Sell
-740
Closed -$234K 102
2024
Q3
$234K Sell
740
-30
-4% -$10.7K 0.11% 97
2024
Q2
$288K Sell
770
-55
-7% -$18.6K 0.14% 79
2024
Q1
$286K Sell
825
-39
-5% -$14.8K 0.14% 79
2023
Q4
$396K Hold
864
0.22% 66
2023
Q3
$420K Hold
864
0.26% 61
2023
Q2
$386K Sell
864
-20
-2% -$10.1K 0.23% 67
2023
Q1
$429K Sell
884
-45
-5% -$22.2K 0.26% 65
2022
Q4
$476K Hold
929
0.3% 61
2022
Q3
$451K Hold
929
0.32% 59
2022
Q2
$435K Hold
929
0.29% 59
2022
Q1
$404K Buy
+929
New +$389K 0.24% 62

Other funds holding HUM

Pavion Blue Capital's HUM Position: Q2 2026 in Review

Pavion Blue Capital opened a new position in Humana (HUM) in Q2 2026: 550 shares worth $218K. The stake represents 0.09% of the portfolio and ranks #103 among its holdings. This is a return to the name: Pavion Blue Capital previously reported a position in HUM as recently as Q3 2024.

Pavion Blue Capital first reported a position in HUM in Q1 2022 and has held it in 12 quarters since. The position peaked at $476K in Q4 2022. 928 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Pavion Blue Capital held 550 shares of Humana worth $218K as of Q2 2026.
  • Humana was a new Pavion Blue Capital position in Q2 2026.
  • Humana made up 0.09% of Pavion Blue Capital's portfolio in Q2 2026, its #103 holding.
  • Pavion Blue Capital first reported a position in Humana in Q1 2022 and has held it in 12 quarters since.
  • Pavion Blue Capital's Humana position peaked at $476K in Q4 2022.
  • 928 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Pavion Blue Capital's 13F filing for Q2 2026, filed 7 Aug 2026.